SERIOUS ADVERSE DRUG REACTIONS WITH LETHAL OUTCOMES: ANALYSIS OF THE RUSSIAN PHARMACOVIGILANCE DATABASE ArticleShmaevskij P.E., Kosyakina N., Cigura D.A., Zatolochina K.E., Zyryanov S.K., Asetskaya I.L., Kazakov A.S.SCIENCE4HEALTH 2019. Клинические и теоретические аспекты современной медицины. 2019. 142 с.
THE ANALYSIS OF ADVERSE DRUG REACTIONS IN THE ELDERLY PATIENTS ArticleTsigura Darya, Shmaevsky Pavel, Zatolochina K.E., Ushkalova E.A.SCIENCE4HEALTH 2019. Клинические и теоретические аспекты современной медицины. 2019. 143 с.
SAFETY AND TOLERABILITY OF NSAIDS: FOCUS ON ACECLOFENAC ArticleUshkalova E.A., Zyryanov S.K., Zalolochina K.E.Медицинский совет. 2019. С. 110-120
INTERFERON BETA: ANALYSIS OF INFORMATION ON ADVERSE REACTIONS AND EVALUATION OF POSSIBILITY OF SIGNAL IDENTIFICATION ArticleZatolochina K.E., Snegireva I.I., Kazakov A.S., Lepakhin V.K.Безопасность и риск фармакотерапии. Том 7. 2019. С. 84-92
ANALYSIS OF ADVERSE DRUG REACTIONS IN ELDERLY PATIENTS ACCORDING TO THE DATABASE OF SPONTANEOUS REPORTS ArticleZatolochina K.E., Ushkalova E.A., Zyryanov S.K., Polivanov V.A.Хирург. 2019. С. 69-73
MURAMYLDIPEPTIDE - BASED COMPOUNDS IN CURRENT MEDICINE: FOCUS ON GLUCOSAMINYLMURAMYL DIPEPTIDE ArticleUshkalova E.A., Zyryanov S.K., Zatolochina K.E.Terapevticheskii Arkhiv. Том 91. 2019. С. 122-127
A PROBLEM OF INHALED DRUG SUBSTITUTIONS: AN ANALYSIS OF DATA FROM RUSSIAN DATABASE ON ADVERSE EVENTS ArticleZyryanov S.K., Zatolochina K.E., Asetskaya I.L.Pulmonologiya. Том 28. 2018. С. 424-429
MYOPATHY CAUSED BY THE INTERACTION OF COLCHICINE AND STATINS ArticleKazakov A.S., Darmostukova M.A., Bukatina T.M., Snegireva I.I., Lepakhin V.K., Zatolochina K.E.Безопасность и риск фармакотерапии. Том 6. 2018. С. 118-122
GENERIC SUBSTITUTIONS OF ANTIEPILEPTIC DRUGS: IS IT POSSIBLE TO PUT AN END TO THE DISCUSSION? ArticleUshkalova E.A., Zyryanov S.K., Zatolochina K.E.Nevrologiya, Neiropsikhiatriya, Psikhosomatika. Том 10. 2018. С. 75-80
PERSPECTIVE FOR USE OF THE RADIONUCLIDE DRUGS IN THE TREATMENT OF MALIGNANT TUMORS IN RUSSIA ArticleZyryanov S.K., Zatolochina K.E.Качественная клиническая практика. 2018. С. 51-57
LEVOFLOXACIN: ANALYSIS OF INFORMATION ON ADVERSE REACTIONS FROM RUSSIAN SPONTANEOUS REPORT DATABASE ArticleZYRYANOV S.K., ZATOLOCHINA K.E., ASETSKAYA I.L.Antibiotiki i Khimioterapiya. Том 63. 2018. С. 46-51
EFFICACIES AND CHEMICAL STRUCTURES OF MODERN DRUGS FOR HEPATITIS C VIRUS TREATMENT ArticleKazakov A.S., Lepakhin V.K., Bukatina T.M., Snegireva I.I., Zatolochina K.É.Pharmaceutical Chemistry Journal. Том 52. 2018. С. 497-500
METHODS OF PHARMACOLOGICAL TREATMENT OF CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION CURRENT APPROACHES TO THE PATIENTS MANAGEMENT ArticleUshkalova E.A., Zyryanov S.K., Zatolochina K.E.Kardiologiia. Том 58. 2018. С. 82-93
СОВРЕМЕННЫЕ РИСКИ ЛЕКАРСТВЕННЫХ ВЗАИМОДЕЙСТВИЙ ПРИ ПРИМЕНЕНИИ ЛОПЕРАМИДА ArticleКазаков А.С., Аляутдин Р.Н., Снегирева И.И., Затолочина К.Э., Букатина Т.М.Experimental and Clinical Pharmacology. Том 80. 2017. С. 36-39
СОВРЕМЕННЫЕ ПОДХОДЫ К СБОРУ И РЕПОРТИРОВАНИЮ ИНФОРМАЦИИ О ПОБОЧНОМ ДЕЙСТВИИ ЛЕКАРСТВЕННЫХ СРЕДСТВ ArticleЗатолочина К.Э., Снегирева И.И., Казаков А.С., Колесникова Е.Ю., Журавлева Е.О., Букатина Т.М., Дармостукова М.А.Безопасность и риск фармакотерапии. 2017. С. 32-38